Studies of atypical retinoids as anti-cancer agents in malignant melanoma
Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions.
Gynecol Oncol 2014 Oct;135(1):118-24. Epub 2014 aug 2
High expression of wee1 is associated with malignancy in vulvar squamous cell carcinoma patients.
BMC Cancer 2013;13():288. Epub 2013 jun 14
Synthetic retinoid CD437 induces apoptosis and acts synergistically with TRAIL receptor-2 agonist in malignant melanoma.
Biochem Biophys Res Commun 2012 Apr;420(3):516-22. Epub 2012 mar 13
PMID: 22446330 - Inngår i doktorgradsavhandlingen
High expression of Wee1 is associated with poor disease-free survival in malignant melanoma: potential for targeted therapy.
PLoS One 2012;7(6):e38254. Epub 2012 jun 12
PMID: 22719872 - Inngår i doktorgradsavhandlingen
Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis
CAncer Biol Ther. 14 (2), 2012
Dacarbazine and agosistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effect in melanoma
PLoS One 7(9) : e45492, 2012
Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival
BMC Cancer 22: 12: 73, 2012